Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$661.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 9 | NTLA | Intellia Therapeutics,… | AGRANT◆ | 13,300 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | NTLA | Intellia Therapeutics,… | AGRANT | 9,200 | — | — | +39.3% | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷◆ | 13,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷◆ | 25,528 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 6,596 | $34.71 | $228.9K | -3.5% | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 13,500 | — | — | +7.6% | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 12,472 | $34.71 | $432.9K | -6.6% | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 25,528 | — | — | +15.5% | Open the original filing on SEC.gov |